Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Source: 
Reuters
snippet: 
  • Novo Nordisk, Pfizer, GSK drugs likely to be in 2027 Medicare negotiations
  • Most drugs already discounted, limited impact seen on Big Pharma
  • Analysts expect price cuts to have bigger bite starting in 2028